{
"id":"mk19_a_np_s10",
"subspecialtyId":"np",
"title":"Kidney Stones",
"jsonContent":{
"type":"section",
"id":"mk19_a_np_s10",
"title":{
"__html":"Kidney Stones"
},
"titleNode":{
"type":"section-title",
"hlId":"64f195",
"children":[
"Kidney Stones"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_np_s10_1",
"title":{
"__html":"Overview"
},
"titleNode":{
"type":"section-title",
"hlId":"3b8782",
"children":[
"Overview"
]
},
"children":[
{
"type":"p",
"hlId":"030d02",
"children":[
"Approximately 7% to 11% of the U.S. population will develop nephrolithiasis, and 50% will have recurrent disease. Risk factors for developing kidney stones include male sex, older age, obesity, diabetes mellitus, the metabolic syndrome, decreased fluid intake, chronic diarrheal states, and Roux-en-Y gastric bypass. Previous antibiotic use is also associated with an increased risk for stone formation."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s10_2",
"title":{
"__html":"Clinical Manifestations"
},
"titleNode":{
"type":"section-title",
"hlId":"65ac9d",
"children":[
"Clinical Manifestations"
]
},
"children":[
{
"type":"p",
"hlId":"2281d9",
"children":[
"Although kidney stones may be asymptomatic and diagnosed as an incidental finding on imaging, the typical presentation is waxing and waning “colicky” flank pain that radiates to the groin. Nausea, vomiting, and dysuria may also be present. Microscopic hematuria is usually noted, although its absence does not exclude a stone."
]
},
{
"type":"p",
"hlId":"7321cd",
"children":[
"Similar symptoms may be present in pyelonephritis and acute abdominal processes, which need to be considered. In addition, the ureteral passage of blood clots can cause renal colic pain."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"ad8f2c",
"children":[
"Kidney stones typically present with waxing and waning “colicky” flank pain that radiates to the groin; nausea, vomiting, and dysuria may also be present."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s10_3",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"042fd2",
"children":[
"Nephrolithiasis should be considered in all patients who present with flank pain. Costovertebral angle tenderness may be present. Microscopic examination of the urine for hematuria, leukocytes that may indicate infection, pH measurement, and crystals is mandatory, but findings are nonspecific. The presence of crystals may help to identify the type of stone (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t03",
"wrapId":"1",
"children":[
"Table 3"
]
}
]
},
")"
]
},
". A complete blood count and complete metabolic panel should be obtained to exclude infection and acute kidney injury, and to screen for common metabolic causes of stone disease."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_a_np_t03"
]
},
{
"type":"p",
"hlId":"abe193",
"children":[
"Definitive diagnosis is made with imaging. Noncontrast helical CT is the gold standard modality because of its high sensitivity and specificity. Although less sensitive than CT, kidney ultrasonography is less expensive, has no radiation exposure, and can be used in pregnant women or when CT is unavailable. Plain abdominal radiography has a low sensitivity and should not be ordered except to follow the stone burden in established disease."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"72fb73",
"children":[
"Noncontrast helical CT is the gold standard modality to diagnose nephrolithiasis; kidney ultrasonography can be used in pregnant women or when CT is unavailable."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s10_4",
"title":{
"__html":"Types of Kidney Stones"
},
"titleNode":{
"type":"section-title",
"hlId":"f249d0",
"children":[
"Types of Kidney Stones"
]
},
"children":[
{
"type":"p",
"hlId":"1095f1",
"children":[
"See ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t30",
"wrapId":"2",
"children":[
"Table 30"
]
}
]
},
" for details on kidney stones and ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t03",
"wrapId":"2",
"children":[
"Table 3"
]
}
]
},
" for images of crystals."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_a_np_t30",
"mk19_a_np_t03"
]
},
{
"type":"section",
"id":"mk19_a_np_s10_4_1",
"title":{
"__html":"Calcium"
},
"titleNode":{
"type":"section-title",
"hlId":"a9640c",
"children":[
"Calcium"
]
},
"children":[
{
"type":"p",
"hlId":"a7c1c7",
"children":[
"Eighty percent of kidney stones contain calcium; most are composed of calcium oxalate, and the remainder are composed of calcium phosphate or a combination of the two."
]
},
{
"type":"p",
"hlId":"f514fb",
"children":[
"Calcium oxalate stones are associated with hypercalciuria, hyperoxaluria, and hypocitraturia. Up to 50% of patients with recurrent stones have elevated 24-hour urine calcium levels. This may be secondary to elevated serum calcium as seen in hyperparathyroidism, sarcoidosis, or excessive vitamin D intake, but is more frequently idiopathic. Hyperoxaluria can be primary or can occur secondary to increased dietary oxalate intake or absorption; decreased calcium in the gastrointestinal tract (as occurs with a low-calcium diet); or binding of calcium to fatty acids (as occurs with malabsorption syndromes). It can also occur after Roux-en-Y gastric bypass surgery or with use of the weight loss drug orlistat, which allows increased absorption of oxalate. High intake of vitamin C, which is metabolized to oxalate, can also cause hyperoxaluria. Because citrate prevents calcium crystal formation, low urine levels are associated with increased stone formation. Urinary citrate is decreased in the presence of metabolic acidosis, as occurs with chronic diarrhea and distal renal tubular acidosis."
]
},
{
"type":"p",
"hlId":"ad8e4d",
"children":[
"Calcium phosphate stones occur when there is persistently elevated urine pH and are associated with distal renal tubular acidosis, hyperparathyroidism, and carbonic anhydrase inhibitors that increase urine pH, such as acetazolamide or topiramate."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s10_4_2",
"title":{
"__html":"Struvite"
},
"titleNode":{
"type":"section-title",
"hlId":"879e38",
"children":[
"Struvite"
]
},
"children":[
{
"type":"p",
"hlId":"cbf753",
"children":[
"Struvite stones occur in the presence of urea-splitting bacteria such as ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Proteus"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Klebsiella"
]
},
", or, less frequently, ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Pseudomonas"
]
},
" species. These bacteria split urea into ammonium, which markedly increases urine pH and results in the precipitation of magnesium ammonium phosphate (struvite). The pH of the urine will be >7.5. Struvite stones commonly produce staghorn calculi (stones that bridge two or more renal calyces) and occur most frequently in older women with chronic urinary tract infections. Because struvite stones are large and grow rapidly, they do not pass into the ureter to cause pain typical of smaller stones. Signs and symptoms typically are related to the underlying infection. Struvite staghorn calculi should be removed to avoid increased morbidity from sepsis and end-stage kidney disease."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s10_4_3",
"title":{
"__html":"Uric Acid"
},
"titleNode":{
"type":"section-title",
"hlId":"07c7da",
"children":[
"Uric Acid"
]
},
"children":[
{
"type":"p",
"hlId":"30f3aa",
"children":[
"Uric acid stones (<10% of stones) develop in the presence of a persistently acidic urine, which decreases the solubility of uric acid. In addition, some individuals overproduce urate, resulting in increased urine uric acid; both gout and hyperuricemia are associated with uric acid stones but are not always present. Chronic diarrhea, resulting in metabolic acidosis and low urine volume, is a common cause of uric acid stones. The metabolic syndrome is also associated with uric acid stone formation. Uric acid stones are radiolucent but are visualized on ultrasound and CT."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s10_4_4",
"title":{
"__html":"Cystine"
},
"titleNode":{
"type":"section-title",
"hlId":"3cbfac",
"children":[
"Cystine"
]
},
"children":[
{
"type":"p",
"hlId":"2d8f07",
"children":[
"Cystine stones (1%-2% of stones) result from cystinuria, an autosomal recessive disease that presents at a young age. These stones are recognized by characteristic hexagonal crystals in the urine (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t03",
"wrapId":"3",
"children":[
"Table 3"
]
}
]
},
")"
]
},
". They may also form staghorn calculi and are less radio-opaque than calcium-containing stones."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_a_np_t03"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"eae395",
"children":[
"Eighty percent of kidney stones contain calcium; most are composed of calcium oxalate, which is associated with hypercalciuria, hyperoxaluria, and hypocitraturia."
]
},
{
"type":"keypoint",
"hlId":"78d9a8",
"children":[
"Staghorn calculi are the result of infection by urea-splitting bacteria such as ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Proteus"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Klebsiella"
]
},
", or, less frequently, ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Pseudomonas"
]
},
" species and can lead to both sepsis and end-stage kidney disease."
]
},
{
"type":"keypoint",
"hlId":"8a8612",
"children":[
"Uric acid stones are radiolucent and are associated with chronic diarrhea, the metabolic syndrome, and gout."
]
},
{
"type":"keypoint",
"hlId":"23cd07",
"children":[
"Cystine stones result from cystinuria, an autosomal recessive disease that presents at a young age."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s10_5",
"title":{
"__html":"Management"
},
"titleNode":{
"type":"section-title",
"hlId":"fe4dbc",
"children":[
"Management"
]
},
"children":[
{
"type":"p",
"hlId":"fd7818",
"children":[
"Acute management of symptomatic nephrolithiasis is aimed at pain management and facilitation of stone passage. Pain can be relieved by NSAIDs and opioids as needed. Stone passage decreases with increasing size. Only 50% of stones >6 mm will pass, generally within 2 weeks, and stones >10 mm are extremely unlikely to pass spontaneously. The data concerning the use of medications such as tamsulosin, nifedipine, silodosin, and tadalafil to enhance stone expulsion are controversial. But because there are few adverse effects attributed to these medications, many experts recommend their use."
]
},
{
"type":"p",
"hlId":"e2ea64",
"children":[
"Urologic intervention is required in all patients with evidence of infection, acute kidney injury, intractable pain, and stones that fail to pass. This may necessitate shock wave lithotripsy, ureteroscopy with laser ablation, or percutaneous nephrolithotomy."
]
},
{
"type":"p",
"hlId":"28cbe7",
"children":[
"Patients should strain their urine to collect stone fragments for chemical analysis if the type of stone is unknown. In addition to the initial evaluation previously described, a 24-hour urine collection for measurement of volume, calcium, oxalate, citrate, uric acid, and sodium should be obtained from all patients with recurrent stones."
]
},
{
"type":"p",
"hlId":"88d30a",
"children":[
"Increased fluid intake is the most important intervention to prevent recurrent disease regardless of stone composition. Urine output should be >2500 mL/d to decrease urine solute concentration."
]
},
{
"type":"p",
"hlId":"16ce85",
"children":[
"Other interventions should be based on findings in the metabolic evaluation and stone analysis (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t30",
"wrapId":"4",
"children":[
"Table 30"
]
}
]
},
")"
]
},
". If hypercalciuria is present, calcium excretion can be decreased by the use of thiazide diuretics. Because calcium excretion parallels sodium excretion, limiting sodium intake will also lower urine calcium. Limiting animal protein may also have a beneficial effect on lowering urine calcium. Unless excessive, dietary calcium should not be restricted because this will increase oxalate absorption. Oxalate excretion can be decreased by limiting foods high in oxalate such as nuts, cocoa, spinach, rhubarb, and beets. Potassium citrate or potassium bicarbonate will increase urinary citrate excretion, which helps prevent crystallization. An additional benefit of potassium citrate is a decrease in renal calcium excretion, possibly related to preventing calcium release from bone."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_a_np_t30"
]
},
{
"type":"p",
"hlId":"0b771a",
"children":[
"In patients with uric acid stones, management consists of increasing the solubility of uric acid by alkalinizing the urine with potassium citrate or bicarbonate; allopurinol can be beneficial if uric acid excretion is elevated."
]
},
{
"type":"p",
"hlId":"bcf7b0",
"children":[
"In patients with cystine stones, urine output should be maintained at >3000 mL/d to decrease solubility of urinary cystine. Urinary cystine excretion can be further reduced by limiting sodium intake and by alkalizing the urine to a pH >7.0."
]
},
{
"type":"p",
"hlId":"55b88c",
"children":[
"Struvite stones typically require urologic intervention. Before any surgical procedure, it is important that active infection be treated with antibiotics to avert sepsis. To prevent recurrent stone formation, all stone fragments must be removed from the kidney. In patients unable to undergo surgery, the urease inhibitor acetohydroxamic acid may reduce urine alkalinity and decrease stone growth; however, this is best used as an adjunct to urologic intervention."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"534843",
"children":[
"Acute management of symptomatic nephrolithiasis includes pain management and facilitation of stone passage."
]
},
{
"type":"keypoint",
"hlId":"3f020b",
"children":[
"Urologic intervention is required in all patients with evidence of infection, acute kidney injury, intractable pain, and stones that fail to pass."
]
},
{
"type":"keypoint",
"hlId":"6d8fff",
"children":[
"Increased fluid intake to >2500 mL/d is the most important intervention to prevent recurrent kidney stones, regardless of stone composition."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s10_6",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Gottlieb M, Long B, Koyfman A. The evaluation and management of urolithiasis in the ED: a review of the literature. Am J Emerg Med. 2018;36:699-706. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29321112",
"target":"_blank"
},
"children":[
"PMID: 29321112"
]
},
" doi:10.1016/j.ajem.2018.01.003"
]
},
{
"type":"reference",
"children":[
"Joshi S, Goldfarb DS. The use of antibiotics and risk of kidney stones. Curr Opin Nephrol Hypertens. 2019;28:311-5. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31145705",
"target":"_blank"
},
"children":[
"PMID: 31145705"
]
},
" doi:10.1097/MNH.0000000000000510"
]
},
{
"type":"reference",
"children":[
"Mayans L. Nephrolithiasis. Prim Care. 2019;46:203-12. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31030821",
"target":"_blank"
},
"children":[
"PMID: 31030821"
]
},
" doi:10.1016/j.pop.2019.02.001"
]
},
{
"type":"reference",
"children":[
"Meltzer AC, Burrows PK, Wolfson AB, et al. Effect of tamsulosin on passage of symptomatic ureteral stones: a randomized clinical trial. JAMA Intern Med. 2018;178:1051-7. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29913020",
"target":"_blank"
},
"children":[
"PMID: 29913020"
]
},
" doi:10.1001/jamainternmed.2018.2259"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_a_np_t03":{
"id":"mk19_a_np_t03",
"number":3,
"bookId":"np",
"title":{
"__html":"Urine Crystals"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"1023d1",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 3. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_np_t03"
}
]
},
"Urine Crystals"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a1fa27",
"class":"col hd l",
"children":[
"Type"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a143f1",
"class":"col hd l",
"children":[
"Morphology"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"020e4f",
"class":"col hd l",
"children":[
"Associated Conditions"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"be53a0",
"class":"col hd l",
"children":[
"Image"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a1cdca",
"class":"cell txt l",
"children":[
"Calcium oxalate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8624eb",
"class":"cell txt l",
"children":[
"Envelope; dumbbell; needle"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bb86d0",
"class":"cell txt l",
"children":[
"Hypercalciuria; hyperoxaluria; calcium oxalate stones; ethylene glycol poisoning"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c33847",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
" ",
{
"type":"table-inline-figure",
"target":"mk19_a_np_f28",
"children":[
"Figure 28"
]
},
" "
]
},
" "
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1a7bd2",
"class":"cell txt l",
"children":[
"Calcium phosphate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e1818c",
"class":"cell txt l",
"children":[
"Prism; needle; star-like clumps"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"28c77b",
"class":"cell txt l",
"children":[
"Distal renal tubular acidosis; urine pH >6.5; tumor lysis syndrome; acute phosphate nephropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bf5c6e",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
" ",
{
"type":"table-inline-figure",
"target":"mk19_a_np_f29",
"children":[
"Figure 29"
]
},
" "
]
},
" "
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67ec1b",
"class":"cell txt l",
"children":[
"Uric acid"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c201c0",
"class":"cell txt l",
"children":[
"Rhomboid; needle; rosette, barrels; hexagonal plates"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6b24d6",
"class":"cell txt l",
"children":[
"Hyperuricemia; gout; diabetes mellitus; obesity; tumor lysis syndrome; urine pH <6.0"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"763796",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
" ",
{
"type":"table-inline-figure",
"target":"mk19_a_np_f30",
"children":[
"Figure 30"
]
},
" "
]
},
" "
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7352eb",
"class":"cell txt l",
"children":[
"Struvite (magnesium ammonium phosphate)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"40bd65",
"class":"cell txt l",
"children":[
"Coffin-lid"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"41a993",
"class":"cell txt l",
"children":[
"Alkaline urine due to chronic urinary tract infection with urease-producing organisms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"36984c",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
" ",
{
"type":"table-inline-figure",
"target":"mk19_a_np_f31",
"children":[
"Figure 31"
]
},
" "
]
},
" "
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3cbfac",
"class":"cell txt l",
"children":[
"Cystine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"28666f",
"class":"cell txt l",
"children":[
"Hexagonal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ba717",
"class":"cell txt l",
"children":[
"Cystinuria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8260bb",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
" ",
{
"type":"table-inline-figure",
"target":"mk19_a_np_f32",
"children":[
"Figure 32"
]
},
" "
]
},
" "
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_np_t30":{
"id":"mk19_a_np_t30",
"number":30,
"bookId":"np",
"title":{
"__html":"Kidney Stone Risk Factors and Therapy"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"86a843",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 30. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_np_t30"
}
]
},
"Kidney Stone Risk Factors and Therapy"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dc09f0",
"class":"col hd l",
"children":[
"Stone Type"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d811a6",
"class":"col hd l",
"children":[
"Risk Factors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8b7674",
"class":"col hd l",
"children":[
"Therapy"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a1cdca",
"class":"cell txt l",
"children":[
"Calcium oxalate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c9ebea",
"class":"cell txt l",
"children":[
"Clinical: hyperparathyroidism; fat malabsorption; excessive vitamin D or C intake"
]
},
" ",
{
"type":"p",
"hlId":"f549cb",
"class":"cell txt l",
"children":[
"Biochemical: hypercalciuria; hyperoxaluria; hypocitraturia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85830f",
"class":"cell txt l",
"children":[
"Increase fluids"
]
},
" ",
{
"type":"p",
"hlId":"ff77e0",
"class":"cell txt l",
"children":[
"Decrease sodium intake"
]
},
" ",
{
"type":"p",
"hlId":"b0e7bd",
"class":"cell txt l",
"children":[
"Decrease animal protein intake"
]
},
" ",
{
"type":"p",
"hlId":"ec330f",
"class":"cell txt l",
"children":[
"Maintain adequate dietary calcium"
]
},
" ",
{
"type":"p",
"hlId":"d6ce3c",
"class":"cell txt l",
"children":[
"Low oxalate diet"
]
},
" ",
{
"type":"p",
"hlId":"6a505c",
"class":"cell txt l",
"children":[
"Thiazide diuretics"
]
},
" ",
{
"type":"p",
"hlId":"155383",
"class":"cell txt l",
"children":[
"Potassium citrate or bicarbonate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1a7bd2",
"class":"cell txt l",
"children":[
"Calcium phosphate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c91af",
"class":"cell txt l",
"children":[
"Clinical: distal renal tubular acidosis; hyperparathyroidism; carbonic anhydrase inhibitors"
]
},
" ",
{
"type":"p",
"hlId":"e0a4b4",
"class":"cell txt l",
"children":[
"Biochemical: elevated urine pH; hypercalciuria; hypocitraturia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85830f",
"class":"cell txt l",
"children":[
"Increase fluids"
]
},
" ",
{
"type":"p",
"hlId":"ff77e0",
"class":"cell txt l",
"children":[
"Decrease sodium intake"
]
},
" ",
{
"type":"p",
"hlId":"b0e7bd",
"class":"cell txt l",
"children":[
"Decrease animal protein intake"
]
},
" ",
{
"type":"p",
"hlId":"ec330f",
"class":"cell txt l",
"children":[
"Maintain adequate dietary calcium"
]
},
" ",
{
"type":"p",
"hlId":"6a505c",
"class":"cell txt l",
"children":[
"Thiazide diuretics"
]
},
" ",
{
"type":"p",
"hlId":"daf462",
"class":"cell txt l",
"children":[
"Treat hyperparathyroidism"
]
},
" ",
{
"type":"p",
"hlId":"155383",
"class":"cell txt l",
"children":[
"Potassium citrate or bicarbonate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67ec1b",
"class":"cell txt l",
"children":[
"Uric acid"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9bb610",
"class":"cell txt l",
"children":[
"Clinical: the metabolic syndrome; gout; diarrheal illnesses; metabolic acidosis"
]
},
" ",
{
"type":"p",
"hlId":"982a63",
"class":"cell txt l",
"children":[
"Biochemical: low urine pH; hyperuricosuria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85830f",
"class":"cell txt l",
"children":[
"Increase fluids"
]
},
" ",
{
"type":"p",
"hlId":"155383",
"class":"cell txt l",
"children":[
"Potassium citrate or bicarbonate"
]
},
" ",
{
"type":"p",
"hlId":"758f82",
"class":"cell txt l",
"children":[
"Acetazolamide"
]
},
" ",
{
"type":"p",
"hlId":"2e4c04",
"class":"cell txt l",
"children":[
"Allopurinol"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"879e38",
"class":"cell txt l",
"children":[
"Struvite"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ae3f31",
"class":"cell txt l",
"children":[
"Clinical: chronic urinary tract infections with urea-splitting organisms"
]
},
" ",
{
"type":"p",
"hlId":"f4076d",
"class":"cell txt l",
"children":[
"Biochemical: elevated urine pH"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ab5934",
"class":"cell txt l",
"children":[
"Treat infection"
]
},
" ",
{
"type":"p",
"hlId":"b95cd4",
"class":"cell txt l",
"children":[
"Urologic intervention"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3cbfac",
"class":"cell txt l",
"children":[
"Cystine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"39ddf9",
"class":"cell txt l",
"children":[
"Clinical: strong family history; young age at onset"
]
},
" ",
{
"type":"p",
"hlId":"8f8a6b",
"class":"cell txt l",
"children":[
"Biochemical: elevated urine cystine; low urine pH"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85830f",
"class":"cell txt l",
"children":[
"Increase fluids"
]
},
" ",
{
"type":"p",
"hlId":"155383",
"class":"cell txt l",
"children":[
"Potassium citrate or bicarbonate"
]
},
" ",
{
"type":"p",
"hlId":"758f82",
"class":"cell txt l",
"children":[
"Acetazolamide"
]
},
" ",
{
"type":"p",
"hlId":"863153",
"class":"cell txt l",
"children":[
"Penicillamine"
]
},
" ",
{
"type":"p",
"hlId":"15f6f4",
"class":"cell txt l",
"children":[
"Tiopronin"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}